Fungi: yeasts

Candida auris

General medical information for education only, not medical advice. Treatment considerations summarize published guidance at drug-class level; therapy is chosen by the treating clinician using susceptibility results, local resistance patterns and current guidelines.

Overview

An emerging, often multidrug-resistant yeast that spreads in healthcare facilities, particularly long-term and ventilator care.

Infections

Bloodstream, wound and ear infection; colonization of skin; candiduria.

Signs and symptoms

Skin colonization (often the groin and armpits) causes no symptoms and is the most common finding. Invasive infection, usually in severely ill patients with lines or other devices: fever and chills that do not improve with antibiotics (bloodstream infection), urinary infection, and wound or ear infection.

Antibiotic and antimicrobial resistance

Often fluconazole-resistant; some strains are resistant to multiple antifungal classes.

Treatment considerations

Echinocandins are usually first-line for infection, guided by susceptibility testing.

Infection control and public health

Nationally notifiable; contact precautions, screening of contacts and disinfectants effective against C. auris.

Candida auris colonies on an agar plate
Candida auris colonies on agar. CDC (S. Lockhart); public domain. Image source
Yeast: budding cells and pseudohyphae, schematic
Yeast: budding cells and pseudohyphae. Schematic, not to scale; InnovexLab.

Sources

  1. CDC. Candida auris.
  2. IDSA. Candidiasis guideline.

Sources accessed November 2026. Links open external sites that InnovexLab does not control.

Medical disclaimer

This page is general educational information summarized from published public-health and professional-society guidance. It is not medical advice, a diagnosis or a treatment recommendation, and reading it does not create a clinician–patient relationship with InnovexLab. Decisions about testing, diagnosis and treatment belong to the treating clinician, using the patient’s history and examination, laboratory and susceptibility results, local resistance patterns and current guidelines. Guidance changes over time; consult the original sources for the latest version. InnovexLab provides this information as is and does not warrant that it is complete or current.

Patients with questions about their health should contact their own healthcare provider. In an emergency, call 911.

Sources, image credits and editorial policy

Discuss a testing program with InnovexLab

Review the panel that fits your patients, its specimen requirements, and how results and billing work.